"Shares Are Positioned to Outperform" - Avalo Therapeutics (AVTX) PT Raised to $17 at Oppenheimer
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on Avalo Therapeutics Inc. (NASDAQ: AVTX) to $17.00 (from $5.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
